Published in:
01-09-2008 | Meeting Report
Second international conference on cancer vaccines/adjuvants/delivery for the next decade (CVADD): Heidelberg, Germany, 10–12 October 2007
Authors:
V. Schirrmacher, P. Beckhove, P. Fournier, V. Umansky
Published in:
Cancer Immunology, Immunotherapy
|
Issue 9/2008
Login to get access
Excerpt
The second international conference on “Cancer Vaccines/Adjuvants and Delivery”, CVADD 2007 was organized at the German Cancer Research Center (DKFZ), Heidelberg, Germany. The main aims were to review the state of the art of cancer vaccination with special attention to clinical application in cancer patients. This report provides a short overview of novel concepts, strategies, and clinical developments in the field following the first CVADD congress (Lisbon, Portugal, 2005). About 180 participants from academia and pharma companies were attracted by the scientific program that consisted of keynote lectures and presentations from 50 international experts. Chairman of the symposium was V. Schirrmacher who was supported by an International Scientific Advisory Board and a local organizing committee. Good memories may remain not only from the lively discussions of 11 scientific sessions and 40 posters, but also from the beauty of Heidelberg in autumn colors and the social evening in the Altstadt (Kulturbrauerei) with local food, drinks and music. The conference bags contained a timely issue of “Vaccine” (Vol. 25, Suppl. 2, 27 Sept. 2007), celebrating 25 years of publication. The topic “Therapeutic Vaccines for Cancer” of this issue includes eight reviews from experts in the field. …